Search Results - "Mueller, Rolf"

Biological degradation of synthetic polyesters—Enzymes as potential catalysts for polyester recycling by Mueller, Rolf-Joachim

“…The depolymerization of polymers by enzymes is of great interest for biodegradable plastics, a group of materials which has been developed as an answer to…”
Get full text

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study by KOCHER, Martin, SOFFIETTI, Riccardo, MOHAMED BEN HASSEL, KOURI, Mauri, VALEINIS, Egils, VAN DEN BERGE, Dirk, COLLETTE, Sandra, COLLETTE, Laurence, MUELLER, Rolf-Peter, ABACIOGLU, Ufuk, VILLA, Salvador, FAUCHON, Francois, BAUMERT, Brigitta G, FARISELLI, Laura, TZUK-SHINA, Tzahala, KORTMANN, Rolf-Dieter, CARRIE, Christian

“…This European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the…”
Get full text

A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results by SOFFIETTI, Riccardo, KOCHER, Martin, HASSEL, Mohamed Ben, KOURI, Mauri, VALEINIS, Egils, DEN BERGE, Dirk Van, MUELLER, Rolf-Peter, TRIDELLO, Gloria, COLLETTE, Laurence, BOTTOMLEY, Andrew, ABACIOGLU, Ufuk M, VILLA, Salvador, FAUCHON, François, BAUMERT, Brigitta G, FARISELLI, Laura, TZUK-SHINA, Tzahala, KORTMANN, Rolf-Dieter, CARRIE, Christian

“…This phase III trial compared adjuvant whole-brain radiotherapy (WBRT) with observation after either surgery or radiosurgery of a limited number of brain…”
Get full text

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial by VON TRESCKOW, Bastian, PLÜTSCHOW, Annette, ZIJLSTRA, Josée M, SOEKLER, Martin, STEIN, Harald, EICH, Hans T, MUELLER, Rolf P, DIEHL, Volker, BORCHMANN, Peter, ENGERT, Andreas, FUCHS, Michael, KLIMM, Beate, MARKOVA, Jana, LOHRI, Andreas, KRAL, Zdenek, GREIL, Richard, TOPP, Max S, MEISSNER, Julia

“…In patients with early unfavorable Hodgkin's lymphoma (HL), combined modality treatment with four cycles of ABVD (adriamycin, bleomycin, vinblastine, and…”
Get full text

Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group by BORCHMANN, Peter, HAVERKAMP, Heinz, RANK, Andreas, PAULUS, Ursula, SMARDOVA, Lenka, HUBER, Christoph, DÖRKEN, Bernd, NERL, Christoph, KRAUSE, Stefan W, MUELLER, Rolf-Peter, FUCHS, Michael, ENGERT, Andreas, DIEHL, Volker, CERNY, Thomas, MARKOVA, Jana, HO, Anthony D, EICH, Hans-Theodor, MUELLER-HERMELINK, Hans Konrad, KANZ, Lothar, GREIL, Richard

“…Eight cycles of BEACOPP(escalated) (escalated dose of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) followed…”
Get full text

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma by Kobe, Carsten, Dietlein, Markus, Franklin, Jeremy, Markova, Jana, Lohri, Andreas, Amthauer, Holger, Klutmann, Susanne, Knapp, Wolfram H., Zijlstra, Josee M., Bockisch, Andreas, Weckesser, Matthias, Lorenz, Reinhard, Schreckenberger, Mathias, Bares, Roland, Eich, Hans T., Mueller, Rolf-Peter, Fuchs, Michael, Borchmann, Peter, Schicha, Harald, Diehl, Volker, Engert, Andreas

“…In the HD15 trial of the German Hodgkin Study Group, the negative predictive value (NPV) of positron emission tomography (PET) using [18F]-fluorodeoxyglucose…”
Get full text

Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy by Koeck, Julia, Abo-Madyan, Yasser, M.D, Lohr, Frank, M.D, Stieler, Florian, Ph.D, Kriz, Jan, M.D, Mueller, Rolf-Peter, M.D, Wenz, Frederik, M.D, Eich, Hans Theodor, M.D

“…Purpose Cure rates of early Hodgkin lymphoma (HL) are high, and avoidance of late complications and second malignancies have become increasingly important…”
Get full text

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer : Implications for response classification by SCHNEIDER, Paul M, BALDUS, Stephan E, HOELSCHER, Arnulf H, METZGER, Ralf, KOCHER, Martin, BONGARTZ, Rudolf, BOLLSCHWEILER, Elfriede, SCHAEFER, Hartmut, THIELE, Juergen, DIENES, Hans P, MUELLER, Rolf P

“…We sought to quantitatively and objectively evaluate histomorphologic tumor regression and establish a relevant prognostic regression classification system for…”
Get full text

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’ by Collette, Sandra, Collette, Laurence, Budiharto, Tom, Horiot, Jean-Claude, Poortmans, Philip M, Struikmans, Henk, Van den Bogaert, Walter, Fourquet, Alain, Jager, Jos J, Hoogenraad, Willem, Mueller, Rolf-Peter, Kurtz, John, Morgan, David A.L, Dubois, Jean-Bernard, Salamon, Emile, Mirimanoff, Rene, Bolla, Michel, Van der Hulst, Marleen, Wárlám-Rodenhuis, Carla C, Bartelink, Harry

“…Abstract The EORTC 22881-10882 trial in 5178 conservatively treated early breast cancer patients showed that a 16 Gy boost dose significantly improved local…”
Get full text

The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis[S] by Laggai, Stephan, Kessler, Sonja M., Boettcher, Stefan, Lebrun, Valérie, Gemperlein, Katja, Lederer, Eva, Leclercq, Isabelle A., Mueller, Rolf, Hartmann, Rolf W., Haybaeck, Johannes, Kiemer, Alexandra K.

“…Liver-specific overexpression of the insulin-like growth factor 2 (IGF2) mRNA binding protein p62/IGF2BP2-2 induces a fatty liver, which highly expresses IGF2…”
Get full text

Angiolactone, a new Butyrolactone isolated from the terrestrial myxobacterium, Angiococcus sp by Raju, Ritesh, Garcia, Ronald, Müller, Rolf

Get full text

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer by Staar, S, Rudat, V, Stuetzer, H, Dietz, A, Volling, P, Schroeder, M, Flentje, M, Eckel, H E, Mueller, R P

“…To demonstrate the efficacy of radiochemotherapy (RCT) as the first choice of treatment for advanced unresectable head-and-neck cancer. To prove an expected…”
Get more information

Cystodienoic acid: a new diterpene isolated from the myxobacterium Cystobacter sp by Raju, Ritesh, Mohr, Kathrin I, Bernecker, Steffen, Herrmann, Jennifer, Müller, Rolf

Get full text

The actin targeting compound Chondramide inhibits breast cancer metastasis via reduction of cellular contractility by Menhofer, Magdalena H, Kubisch, Rebekka, Schreiner, Laura, Zorn, Matthias, Foerster, Florian, Mueller, Rolf, Raedler, Joachim O, Wagner, Ernst, Vollmar, Angelika M, Zahler, Stefan

“…A major player in the process of metastasis is the actin cytoskeleton as it forms key structures in both invasion mechanisms, mesenchymal and amoeboid…”
Get full text

Parotid cancer: Impact of changes from the 1997 to the 2002 American Joint Committee on Cancer classification on outcome prediction by Schroeder, Ursula, Groppe, Daniela, Mueller, Rolf‐Peter, Guntinas‐Lichius, Orlando

“…BACKGROUND. The TNM classification [American Joint Committee on Cancer (AJCC)] of salivary gland cancer was revised again in 2002. In the present study, the…”
Get full text

Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma by Kessler, Sonja M, Simon, Yvette, Gemperlein, Katja, Gianmoena, Kathrin, Cadenas, Cristina, Zimmer, Vincent, Pokorny, Juliane, Barghash, Ahmad, Helms, Volkhard, van Rooijen, Nico, Bohle, Rainer M, Lammert, Frank, Hengstler, Jan G, Mueller, Rolf, Haybaeck, Johannes, Kiemer, Alexandra K

“…Non-alcoholic steatohepatitis (NASH) represents a risk factor for the development of hepatocellular carcinoma (HCC) and is characterized by quantitative and…”
Get full text

Anti-MRSA-acting carbamidocyclophanes H–L from the Vietnamese cyanobacterium Nostoc sp. CAVN2 by Preisitsch, Michael, Harmrolfs, Kirsten, Pham, Hang TL, Heiden, Stefan E, Füssel, Anna, Wiesner, Christoph, Pretsch, Alexander, Swiatecka-Hagenbruch, Monika, Niedermeyer, Timo HJ, Müller, Rolf, Mundt, Sabine

“…The methanol extract of the Vietnamese freshwater cyanobacterium Nostoc sp. CAVN2 exhibited cytotoxic effects against MCF-7 and 5637 cancer cell lines as well…”
Get full text

Oleamycins A and B: new antibacterial cyclic hexadepsipeptides isolated from a terrestrial Streptomyces sp by Raju, Ritesh, Gromyko, Oleksandr, Andriy, Butsiak, Fedorenko, Viktor, Luzhetskyy, Andriy, Müller, Rolf

Get full text

Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: When should they be considered and which questions remain open? by Lohr, Frank, Georg, Dietmar, Cozzi, Luca, Eich, Hans Theodor, Weber, Damien C., Koeck, Julia, Knäusl, Barbara, Dieckmann, Karin, Abo-Madyan, Yasser, Fiandra, Christian, Mueller, Rolf-Peter, Engert, Andreas, Ricardi, Umberto

“…Purpose Hodgkin lymphoma (HL) is a highly curable disease. Reducing late complications and second malignancies has become increasingly important. Radiotherapy…”
Get full text

High Specificity of Quantitative Excision Repair Cross-Complementing 1 Messenger RNA Expression for Prediction of Minor Histopathological Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer by WARNECKE-EBERZ, Ute, METZGER, Ralf, MUELLER, Rolf P, DANENBERG, Peter V, HOELSCHER, Arnulf H, SCHNEIDER, Paul M, MIYAZONO, Futoshi, BALDUS, Stephan E, NEISS, Susanne, BRABENDER, Jan, SCHAEFER, Hartmut, DOERFLER, Walter, BOLLSCHWEILER, Elfriede, DIENES, Hans P

“…Purpose: The excision repair cross-complementing 1 ( ERCC1 ) gene is coding for a nucleotide excision repair protein involved in the repair of radiation- and…”
Get full text